Demonstrates effective trifluoromethylsulfinylation of sulfoximines, suggesting efficient synthesis methods.
Sulfoximines are privileged motifs in medicinal chemistry, and direct installation of the −SOCF3 group on these scaffolds remains challenging. Herein, we report an Et3N-catalyzed N-trifluoromethylsulfinylation of sulfoximines using the bench-stable reagent N-trifluoromethylsulfinylphthalimide under mild conditions. The process furnishes N-trifluoromethylsulfinylated sulfoximines in moderate to excellent yields and features a broad scope with high functional-group tolerance. Notably, phthalimide is formed as a valuable, readily recoverable coproduct, enabling a waste-minimized and sustainable process. Translation to a continuous-flow microreactor enables ultrafast reactivity with a residence time of only 6 s, delivering products in up to 86% yield. Mechanistic studies, gram-scale experiments, and structurally complex bioactive molecules further underscore the synthetic and practical utility of this transformation.
No takes yet. Share an insight, caveat, or question.
Govindan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: